% alzhub.org library filter
% Source: https://alzhub.org/research?author=Wegiel+J&access=free
% 6 entries, in the order the page lists them. Built from alzhub.org's own records.
% 0 entries have no readable author in the source record and carry no author field.

@article{im2023-37494443,
  author  = {Im, E. and Jiang, Y. and Stavrides, P. H. and Darji, S. and Erdjument-Bromage, H. and Neubert, T. A. and Choi, J. Y. and Wegiel, J. and others},
  title   = {{Lysosomal dysfunction in Down syndrome and Alzheimer mouse models is caused by v-ATPase inhibition by Tyr682-phosphorylated APP βCTF}},
  journal = {Science advances},
  year    = {2023},
  doi     = {10.1126/sciadv.adg1925},
  pmid    = {37494443},
  url     = {https://doi.org/10.1126/sciadv.adg1925}
}

@article{wegiel2007-17237937,
  author  = {Wegiel, J. and Kuchna, I. and Nowicki, K. and Frackowiak, J. and Mazur-Kolecka, B. and Imaki, H. and Mehta, P. D. and others},
  title   = {{Intraneuronal Abeta immunoreactivity is not a predictor of brain amyloidosis-beta or neurofibrillary degeneration}},
  journal = {Acta neuropathologica},
  year    = {2007},
  doi     = {10.1007/s00401-006-0191-4},
  pmid    = {17237937},
  url     = {https://doi.org/10.1007/s00401-006-0191-4}
}

@article{liu2008-18509201,
  author  = {Liu, F. and Liang, Z. and Wegiel, J. and Hwang, Y. W. and Iqbal, K. and Grundke-Iqbal, I. and Ramakrishna, N. and Gong, C. X.},
  title   = {{Overexpression of Dyrk1A contributes to neurofibrillary degeneration in Down syndrome}},
  journal = {FASEB journal : official publication of the Federation of American Societies for Experimental Biology},
  year    = {2008},
  doi     = {10.1096/fj.07-104539},
  pmid    = {18509201},
  url     = {https://doi.org/10.1096/fj.07-104539}
}

@article{shi2008-18658135,
  author  = {Shi, J. and Zhang, T. and Zhou, C. and Chohan, M. O. and Gu, X. and Wegiel, J. and Zhou, J. and Hwang, Y. W. and others},
  title   = {{Increased dosage of Dyrk1A alters alternative splicing factor (ASF)-regulated alternative splicing of tau in Down syndrome}},
  journal = {The Journal of biological chemistry},
  year    = {2008},
  doi     = {10.1074/jbc.m802645200},
  pmid    = {18658135},
  url     = {https://doi.org/10.1074/jbc.m802645200}
}

@article{wegiel2011-21156028,
  author  = {Wegiel, J. and Gong, C. X. and Hwang, Y. W.},
  title   = {{The role of DYRK1A in neurodegenerative diseases}},
  journal = {The FEBS journal},
  year    = {2011},
  doi     = {10.1111/j.1742-4658.2010.07955.x},
  pmid    = {21156028},
  url     = {https://doi.org/10.1111/j.1742-4658.2010.07955.x}
}

@article{wegiel2011-21157379,
  author  = {Wegiel, J. and Kaczmarski, W. and Barua, M. and Kuchna, I. and Nowicki, K. and Wang, K. C. and Yang, S. M. and others},
  title   = {{Link between DYRK1A overexpression and several-fold enhancement of neurofibrillary degeneration with 3-repeat tau protein in Down syndrome}},
  journal = {Journal of neuropathology and experimental neurology},
  year    = {2011},
  doi     = {10.1097/nen.0b013e318202bfa1},
  pmid    = {21157379},
  url     = {https://doi.org/10.1097/nen.0b013e318202bfa1}
}